Treating diabetes to accepted standards of care: A 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States

Efficient targeting of financial resources toward the goal of lowering HbA1c in line with published guidelines could lead to financial savings in the range from nearly $35 billion to $72 billion over the next 10 years.